Gibson Christopher's Form 4 filing
Recursion Pharmaceuticals, Inc. (RXRX) · filed Apr 18, 2022
- Accession no.
- 0001209191-22-024679
- Filed
- Apr 18, 2022
- Trade date
- Apr 14, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 10 non-derivative transactions and 5 derivative transactions. Open-market sales total $279.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gibson ChristopherCIK 0001856369 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 14, 2022 | Class A Common Stock | MOption exerciseAcquired | +44,010 | $2.48 | +$109,144.8 | 384,134 | Direct | |
| Apr 14, 2022 | Class A Common Stock | SSaleDisposed | −16,017 | $7.62F2 | −$122,049.54 | 368,117 | Direct | |
| Apr 14, 2022 | Class A Common Stock | CConversionAcquired | +18,500 | $0.00F4 | $0 | 386,617 | Direct | |
| Apr 14, 2022 | Class A Common Stock | SSaleDisposed | −18,500 | $7.51F5 | −$138,935 | 368,117 | Direct | |
| Apr 14, 2022 | Class A Common Stock | CConversionAcquired | +500 | $0.00F4 | $0 | 500 | Indirect | |
| Apr 14, 2022 | Class A Common Stock | SSaleDisposed | −500 | $7.50F6 | −$3,750 | 0 | Indirect | |
| Apr 14, 2022 | Class A Common Stock | CConversionAcquired | +1,000 | $0.00F4 | $0 | 1,000 | Indirect | |
| Apr 14, 2022 | Class A Common Stock | SSaleDisposed | −1,000 | $7.51F6 | −$7,510 | 0 | Indirect | |
| Apr 14, 2022 | Class A Common Stock | CConversionAcquired | +1,000 | $0.00F4 | $0 | 1,000 | Indirect | |
| Apr 14, 2022 | Class A Common Stock | SSaleDisposed | −1,000 | $7.51F6 | −$7,510 | 0 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 14, 2022 | Class A Common Stock | CConversionDisposed | −6,948,334 | $0.00F4 | $0 | 6,948,334 | Direct | |
| Apr 14, 2022 | Class A Common Stock | MOption exerciseDisposed | −1,251,304 | $0.00 | $0 | 1,251,304 | Direct | |
| Apr 14, 2022 | Class A Common Stock | CConversionDisposed | −547,500 | $0.00F4 | $0 | 547,500 | Indirect | |
| Apr 14, 2022 | Class A Common Stock | CConversionDisposed | −545,000 | $0.00F4 | $0 | 545,000 | Indirect | |
| Apr 14, 2022 | Class A Common Stock | CConversionDisposed | −141,875 | $0.00F4 | $0 | 141,875 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $7.61 to $7.65. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F4
Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
Referenced by the price of 4 transactions in Table I and 4 transactions in Table II.
- F5
This transaction was executed in multiple trades at prices ranging from $7.35 to $7.64. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $7.36 to $7.60. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 3 transactions in Table I.